Literature DB >> 826966

Differential actions of dopamine agonists and antagonists on the gamma-butyrolactone-induced in mouse brain dopamine.

G Gianutsos, J E Thornburg, K E Moore.   

Abstract

gamma-Butyrolactone (GBL) increased the dopamine concentration in the forebrain of the mouse. Apomorphine dose-dependently antagonized the GBL effect, while piribedil was less effective. Haloperidol prevented the antagonism of GBL by apomorphine but pimozide was ineffective in blocking apomorphine. After chronic treatment with haloperidol or pimozide, there was no alteration of the maximum GBL-induced increase in dopamine nor was there any significant change in the antagonism by apomorphine, although a trend toward increased sensitivity to apomorphine was noted in the group withdrawn from haloperidol. These results suggest that in the mouse, haloperidol is a more effective antagonist of presynaptic dopamine autoreceptors than pimozide, while apomorphine is a better presynaptic agonist than piribedil.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 826966     DOI: 10.1007/BF00426836

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  A SENSITIVE METHOD FOR SPECTROPHOTOFLUOROMETRIC ASSAY OF CATECHOLAMINES.

Authors:  C C CHANG
Journal:  Int J Neuropharmacol       Date:  1964-12

2.  Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

Authors:  D Tarsy; R J Baldessarini
Journal:  Neuropharmacology       Date:  1974-11       Impact factor: 5.250

3.  Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway.

Authors:  J R Walters; R H Roth; G K Aghajanian
Journal:  J Pharmacol Exp Ther       Date:  1973-09       Impact factor: 4.030

4.  Behavioral evidence for dopaminergic supersensitivity after chronic haloperidol.

Authors:  G Gianutsos; R B Drawbaugh; M D Hynes; H Lal
Journal:  Life Sci       Date:  1974-03-01       Impact factor: 5.037

5.  A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice.

Authors:  J E Thornburg; K E Moore
Journal:  Neuropharmacology       Date:  1974-03       Impact factor: 5.250

6.  Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum.

Authors:  J R Walters; R H Roth
Journal:  Biochem Pharmacol       Date:  1972-08-01       Impact factor: 5.858

7.  ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors.

Authors:  H Corrodi; L O Farnebo; K Fuxe; B Hamberger; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1972-11       Impact factor: 4.432

8.  Stimulation of brain dopamine synthesis by gamma-hydroxybutyrate.

Authors:  P F Spano; A Tagliamonte; P Tagliamonte; G L Gessa
Journal:  J Neurochem       Date:  1971-10       Impact factor: 5.372

9.  Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow.

Authors:  J R Walters; R H Roth
Journal:  J Pharmacol Exp Ther       Date:  1974-10       Impact factor: 4.030

10.  Supersensitivity to dopaminergic agonists induced by haloperidol.

Authors:  J E Thornburg; K E Moore
Journal:  Natl Inst Drug Abuse Res Monogr Ser       Date:  1975-11
View more
  13 in total

Review 1.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

2.  Differential behavioral and biochemical effects of four dopaminergic agonists.

Authors:  G Gianutsos; K E Moore
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

3.  Pre- and postsynaptic dopaminergic activities of U-86170F.

Authors:  R A Lahti; D L Evans; L M Figur; R M Huff; M W Moon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

4.  Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively.

Authors:  N E Andén; K Gołembiowska-Nikitin; U Thornström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000

5.  Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.

Authors:  M J Bannon; E B Bunney; J R Zigun; L R Skirboll; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

6.  Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.

Authors:  G Bagdy; A Perényi; E Frecska; K Révai; Z Papp; M I Fekete; M Arató
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Role of dopamine storage function in the control of rat striatal tyrosine hydroxylase activity.

Authors:  B A McMillen; P A Shore
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

8.  Effect of lergotrile on 3,4-dihydroxyphenylacetic acid (DOPAC) concentration and dopamine turnover in rat brain.

Authors:  R W Fuller; K W Perry
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

9.  Increase in mouse brain dopamine content by baclofen: effects of apomorphine and neuroleptics.

Authors:  G Gianutsos; K E Moore
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

10.  Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide.

Authors:  R M Post; D C Jimerson; W E Bunney; F K Goodwin
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.